TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18782780

Group type: EXPERIMENTAL
Intervention: enfuvirtide+HAART
Number of subjects: 47

Group type: COMPARATOR
Intervention: HAART
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: enfuvirtide+HAART (maintenance phase)
Number of subjects: 47

Group type: COMPARATOR
Intervention: HAART (maintenance phase)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: enfuvirtide+HAART continuation arm
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: enfuvirtide discontinuation arm
Number of subjects: 47

Group type: COMPARATOR
Intervention: HAART arm
Number of subjects: 47
Study: 16815485

Group type: EXPERIMENTAL
Intervention: Arginine-supplemented diet (AG; n = 14)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Isocaloric isonitrogenous diet (CG; n = 14)
Number of subjects: 28
Study: 14531537

Group type: EXPERIMENTAL
Intervention: Cholecystectomy
Number of subjects: 64

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 64
Study: 10673875

Group type: EXPERIMENTAL
Intervention: Midazolam 0.05 mg kg‐1 i.v. (group TM)
Number of subjects: 25

Group type: COMPARATOR
Intervention: No midazolam (group T0)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Midazolam premedication
Number of subjects: 25
Study: 8535649

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX)
Number of subjects: 0
Study: 2405883

Group type: EXPERIMENTAL
Intervention: labetalol
Number of subjects: 27

Group type: COMPARATOR
Intervention: atenolol
Number of subjects: 27
Study: 7353128

Group type: EXPERIMENTAL
Intervention: Dextran 70
Number of subjects: 3984

Group type: COMPARATOR
Intervention: Low-dose heparin
Number of subjects: 3984
Study: 31233409

Group type: EXPERIMENTAL
Intervention: Propofol with dexmedetomidine (0.3 μg/kg)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Propofol with dexmedetomidine
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 101
Study: 28276946

Group type: EXPERIMENTAL
Intervention: Humorous story line about unprotected sex
Number of subjects: 161

Group type: COMPARATOR
Intervention: Identical story line with humor edited out
Number of subjects: 161

Group type: COMPARATOR
Intervention: Story line unrelated to unprotected sex
Number of subjects: 161
Study: 25139667

Group type: EXPERIMENTAL
Intervention: Adalimumab plus methotrexate
Number of subjects: 1467
Study: 24171019

Group type: EXPERIMENTAL
Intervention: Calcium enriched mixture (CEM)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: ProRoot mineral trioxide aggregate (MTA)
Number of subjects: 42
Study: 21562425

Group type: EXPERIMENTAL
Intervention: 3 mg intranasal nicotine
Number of subjects: 179
Study: 19229791

Group type: EXPERIMENTAL
Intervention: Whole-body MRI (WB-MRI)
Number of subjects: 213

Group type: COMPARATOR
Intervention: Bone Scintigraphy (BS)
Number of subjects: 213
Study: 16846536

Group type: EXPERIMENTAL
Intervention: Topiramate 50 mg/day
Number of subjects: 469

Group type: EXPERIMENTAL
Intervention: Topiramate 100 mg/day
Number of subjects: 469

Group type: EXPERIMENTAL
Intervention: Topiramate 200 mg/day
Number of subjects: 469

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 469
Study: 12759322

Group type: EXPERIMENTAL
Intervention: Strength training group (high-intensity isometric neck strengthening and stabilization exercises with an elastic band)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Endurance training group (dynamic neck exercises including lifting the head up from supine and prone positions)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group (no specific intervention)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Both training groups (strength and endurance)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Strength training group
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Endurance training group
Number of subjects: 180
Study: 11758634

Group type: EXPERIMENTAL
Intervention: Acetaminophen 40 mg/kg
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Acetaminophen 100 mg/kg
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 9586749

Group type: EXPERIMENTAL
Intervention: Entrance high contrast binocular acuity
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Best corrected low contrast monocular acuity
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Visual acuity score at Repeat Visit
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Intraclass correlation coefficients
Number of subjects: 134
Study: 7795014

Group type: EXPERIMENTAL
Intervention: Awareness program (video discussion)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Control group (no discussion)
Number of subjects: 124
Study: 2492011

Group type: EXPERIMENTAL
Intervention: Beta- and gamma-interferon combination therapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 20
Study: 235939

Group type: EXPERIMENTAL
Intervention: Ritodrine treatment
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Infants weighing less than 2300 grams
Number of subjects: 63
Study: 7357339

Group type: EXPERIMENTAL
Intervention: Metronidazole in patients with normal or inflamed appendix (n=96)
Number of subjects: 263

Group type: COMPARATOR
Intervention: Control group (n=91)
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Ampicillin in patients with gangrenous or perforated appendices (n=32)
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Metronidazole in patients with gangrenous or perforated appendices (n=31)
Number of subjects: 263
Study: 31490321

Group type: EXPERIMENTAL
Intervention: Intervention worksites
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control worksites
Number of subjects: 63
Study: 29270789

Group type: EXPERIMENTAL
Intervention: ImpACT (SoC plus four individual and three group sessions)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Standard of Care (SoC: three adherence counseling sessions)
Number of subjects: 64
Study: 26851187

Group type: EXPERIMENTAL
Intervention: Naptumomab estafenatox (Nap) + IFNα
Number of subjects: 513

Group type: COMPARATOR
Intervention: IFNα
Number of subjects: 513
Study: 24216124

Group type: EXPERIMENTAL
Intervention: eGFR attributable to disease
Number of subjects: 6337

Group type: EXPERIMENTAL
Intervention: eGFR attributable to normal aging
Number of subjects: 6337
Study: 22108900

Group type: EXPERIMENTAL
Intervention: Communities That Care (CTC) prevention system
Number of subjects: 24
Study: 19880586

Group type: EXPERIMENTAL
Intervention: Walnut-enriched ad libitum diet (56 g walnuts/day)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Ad libitum diet without walnuts
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Walnut-enriched diet
Number of subjects: 24
Study: 17984413

Group type: EXPERIMENTAL
Intervention: Glutamine supplementation (l-glutamine, 0.3 g/kg per day)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (no glutamine supplementation)
Number of subjects: 90
Study: 16167232

Group type: EXPERIMENTAL
Intervention: Titanoreine cream (n=133)
Number of subjects: 252

Group type: COMPARATOR
Intervention: Compound carraghenates suppository (n=119)
Number of subjects: 252
Study: 12001769

Group type: EXPERIMENTAL
Intervention: Underwater labor
Number of subjects: 59

Group type: COMPARATOR
Intervention: Classical deliveries
Number of subjects: 59
Study: 9469683

Group type: EXPERIMENTAL
Intervention: 6-hour infusion of furosemide (0.1 mg/kg loading dose, followed by 0.9 mg/kg over 6 hours)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Bolus administration of furosemide (1 mg/kg over 2 minutes, followed by a 6-hour placebo infusion)
Number of subjects: 30
Study: 7631260

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy with carboplatin, ifosfamide, and etoposide followed by carboplatin and vindesine, and hyperfractionated accelerated radiotherapy (1.5 Gy 10 times per week for a total of 45 Gy in 3 weeks)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Neoadjuvant treatment
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Multimodal treatment
Number of subjects: 25
Study: 2241007

Group type: EXPERIMENTAL
Intervention: Trimetazidine (20 mg tid)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 720378

Group type: EXPERIMENTAL
Intervention: Noradrenaline plus propranolol 10 microgram/ml
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Noradrenaline plus propranolol 10 microgram/ml plus oxprenolol 3 microgram/ml
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Noradrenaline plus propranolol 13 microgram/ml
Number of subjects: 8

Group type: COMPARATOR
Intervention: Noradrenaline alone
Number of subjects: 8
Study: 31985080

Group type: EXPERIMENTAL
Intervention: Fentanyl (1 µg/kg) administered at the end of surgery
Number of subjects: 140

Group type: COMPARATOR
Intervention: Fentanyl (1 µg/kg) administered 10 to 15 minutes before the end of surgery
Number of subjects: 140
Study: 31162894

Group type: EXPERIMENTAL
Intervention: Galavit in combination with standard therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard antibiotic therapy
Number of subjects: 60
Study: 28608899

Group type: EXPERIMENTAL
Intervention: Clustered approach using median sensor values from groups of 6, 8, and 21 sensors
Number of subjects: 21

Group type: COMPARATOR
Intervention: Individual sensors
Number of subjects: 21
Study: 25631483

Group type: COMPARATOR
Intervention: Intravitreal ranibizumab (IVR)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Intravitreal bevacizumab (IVB)
Number of subjects: 75
Study: 23503369

Group type: EXPERIMENTAL
Intervention: Propofol and remifentanil
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Noxious stimulation
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 176
Study: 20823089

Group type: EXPERIMENTAL
Intervention: 5% albumin infusion before exchange transfusion
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 42
Study: 19211182

Group type: EXPERIMENTAL
Intervention: Mild hypothermia (32‐34 degrees C during 24h)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: MRI evaluation
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Autopsy
Number of subjects: 20
Study: 17314110

Group type: EXPERIMENTAL
Intervention: Lp-PLA(2) levels in ACS patients (median 305 ng/mL in FRISC II, 373 ng/mL in GUSTO IV)
Number of subjects: 2266

Group type: COMPARATOR
Intervention: Healthy controls (median Lp-PLA(2) 254 ng/mL)
Number of subjects: 2266
Study: 15205386

Group type: EXPERIMENTAL
Intervention: Tolbutamide, Ibuprofen, Fluvastatin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: In vitro drug-drug interaction potential
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluvastatin (without protein binding)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Well stirred prediction model and CL(int) calculations
Number of subjects: 0
Study: 11535487

Group type: EXPERIMENTAL
Intervention: Defibrillation as the primary treatment for VF
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Achieving restoration of spontaneous circulation (ROSC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Resuscitation from cardiac arrest divided into two phases
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Focus on heart and brain during resuscitation
Number of subjects: 0
Study: 9252717

Group type: EXPERIMENTAL
Intervention: Ifosfamide (IFO), Vinorelbine (VNB), Cisplatin (DDP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ifosfamide (IFO), Vinorelbine (VNB)
Number of subjects: 0
Study: 8495122

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass surgery
Number of subjects: 0
Study: 3791847

Group type: EXPERIMENTAL
Intervention: Use of an information leaflet
Number of subjects: 0

Group type: COMPARATOR
Intervention: No information leaflet
Number of subjects: 0
Study: 31593002

Group type: EXPERIMENTAL
Intervention: Active rTMS (5 daily sessions, 500 pulses per session at 5 Hz)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Sham rTMS (5 daily sessions)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Active rTMS (4 weekly sessions, open-label continuous trial)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Sham rTMS (4 weekly sessions, open-label continuous trial)
Number of subjects: 144
Study: 31201481

Group type: EXPERIMENTAL
Intervention: Denosumab 60 mg every 6 months
Number of subjects: 2207

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2207
Study: 28797427

Group type: EXPERIMENTAL
Intervention: Low-level tragus stimulation (LL-TS)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Sham stimulation (Control)
Number of subjects: 95
Study: 25092797

Group type: EXPERIMENTAL
Intervention: Rescuer-limited CPR
Number of subjects: 90

Group type: COMPARATOR
Intervention: 2-min switched CPR
Number of subjects: 90
Study: 23496803

Group type: EXPERIMENTAL
Intervention: Probiotic dairy product (active group)
Number of subjects: 179

Group type: COMPARATOR
Intervention: Non-probiotic dairy product (placebo group)
Number of subjects: 179
Study: 21785864

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Baclofen
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 16
Study: 17623246

Group type: EXPERIMENTAL
Intervention: Laparoscopic colorectal resections
Number of subjects: 15

Group type: COMPARATOR
Intervention: Conventional colorectal resections
Number of subjects: 15
Study: 17135993

Group type: EXPERIMENTAL
Intervention: Trauma-Focused Cognitive Behavioral Therapy (TF-CBT)
Number of subjects: 183

Group type: COMPARATOR
Intervention: Child-Centered Therapy (CCT)
Number of subjects: 183
Study: 14581113

Group type: EXPERIMENTAL
Intervention: High frequency (110 Hz), high intensity (strong but comfortable), segmental stimulation for 30 min
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: High frequency (110 Hz), high intensity (strong but comfortable), combined stimulation for 30 min
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Low frequency (4 Hz), strong but comfortable intensity, segmental stimulation for 30 min
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Low frequency (4 Hz), highest tolerable intensity, segmental stimulation for 30 min
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: High frequency (110 Hz), highest tolerable intensity, segmental stimulation for 30 min
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Low frequency (4 Hz), strong but comfortable intensity, combined stimulation for 30 min
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Low frequency (4 Hz), highest tolerable intensity, combined stimulation for 30 min
Number of subjects: 240

Group type: COMPARATOR
Intervention: Sham TENS
Number of subjects: 240
Study: 8866039

Group type: EXPERIMENTAL
Intervention: Fast-dissolving ketorolac tablet
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Medium-1 dissolving ketorolac tablet
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Medium-2 dissolving ketorolac tablet
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Slow-dissolving ketorolac tablet
Number of subjects: 12

Group type: COMPARATOR
Intervention: All formulations
Number of subjects: 12
Study: 1378148

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 14

Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 14
Study: 6848932

Group type: EXPERIMENTAL
Intervention: Whey-based infant formula
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Milk from mothers of preterm infants
Number of subjects: 60

Group type: COMPARATOR
Intervention: Milk from mothers of term infants
Number of subjects: 60
Study: 30769861

Group type: EXPERIMENTAL
Intervention: Habitual afternoon schedule
Number of subjects: 20

Group type: COMPARATOR
Intervention: Unconventional morning schedule
Number of subjects: 20
Study: 28245193

Group type: EXPERIMENTAL
Intervention: Video-based problem-based learning
Number of subjects: 120

Group type: COMPARATOR
Intervention: Paper-based problem-based learning
Number of subjects: 120
Study: 25369272

Group type: EXPERIMENTAL
Intervention: AM3 (Inmunoferón®)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 24313583

Group type: EXPERIMENTAL
Intervention: Maltitol chewing-gum
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: Xylitol chewing-gum
Number of subjects: 258

Group type: COMPARATOR
Intervention: Gum base (placebo)
Number of subjects: 258

Group type: COMPARATOR
Intervention: No gum (negative control)
Number of subjects: 258
Study: 21629020

Group type: EXPERIMENTAL
Intervention: Social contact with perceived close partners
Number of subjects: 197

Group type: COMPARATOR
Intervention: Depressive symptoms
Number of subjects: 197

Group type: COMPARATOR
Intervention: Time spent with perceived close partners
Number of subjects: 197
Study: 19920413

Group type: EXPERIMENTAL
Intervention: Continuous preperitoneal wound infusion (CPWI) of 0.2% ropivacaine at 10 mL/hr for 48 hrs
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional parenteral analgesia (intravenously administered morphine via patient‐controlled analgesia and acetaminophen) without parietal analgesia
Number of subjects: 20
Study: 16426099

Group type: EXPERIMENTAL
Intervention: Maternal depression (current major depressive episode)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Atypical depressive features in mothers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Maternal history of suicide attempts
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Maternal comorbid panic disorder with agoraphobia
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Maternal irritable depression
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Maternal substance use disorders
Number of subjects: 0
Study: 15700916

Group type: EXPERIMENTAL
Intervention: Cessation treatment for smokers with past major depressive disorder
Number of subjects: 85
Study: 12567752

Group type: EXPERIMENTAL
Intervention: Fresh corneas
Number of subjects: 36

Group type: COMPARATOR
Intervention: Cryopreserved corneas
Number of subjects: 36
Study: 8510514

Group type: EXPERIMENTAL
Intervention: 23 g parboiled white rice (20 g available carbohydrate)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: 46 g parboiled white rice (40 g available carbohydrate)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: 69 g parboiled white rice (60 g available carbohydrate)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control for glucosuria after 20 g carbohydrate
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control for glucosuria after 40 g carbohydrate
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control for glucosuria after 60 g carbohydrate
Number of subjects: 7
Study: 3327883

Group type: EXPERIMENTAL
Intervention: Spiramycin
Number of subjects: 1

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1
Study: 29447382

Group type: EXPERIMENTAL
Intervention: Group acupuncture (20 treatments over 10 weeks, 900 minutes total)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Group education (20 sessions over 10 weeks, 900 minutes total)
Number of subjects: 30
Study: 27309790

Group type: EXPERIMENTAL
Intervention: Education based on the Roy Adaptation Model
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 82
Study: 26526558

Group type: EXPERIMENTAL
Intervention: Transperineal biopsy (TPBx)
Number of subjects: 339

Group type: COMPARATOR
Intervention: Transrectal biopsy (TRBx)
Number of subjects: 339
Study: 24340417

Group type: EXPERIMENTAL
Intervention: Facilitated FCR with bunnies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Facilitated FCR with clowns
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care model facilitated by distracted residents and overbearing attending physicians
Number of subjects: 0
Study: 20179903

Group type: EXPERIMENTAL
Intervention: Retropubic or transobturator sling procedure
Number of subjects: 537

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 537
Study: 17712352

Group type: EXPERIMENTAL
Intervention: LY544344 16 mg b.i.d.
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: LY544344 8 mg b.i.d.
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study: 16671425

Group type: EXPERIMENTAL
Intervention: Indomethacin (IND) 100 mg transrectally and 6 mg/kg/day for 14 days
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Indomethacin (IND) 6 mg/kg/day for 14 days
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Indomethacin (IND)
Number of subjects: 46
Study: 14654744

Group type: EXPERIMENTAL
Intervention: Active antihypertensive treatment
Number of subjects: 744

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 744
Study: 10380022

Group type: EXPERIMENTAL
Intervention: C3F8 gas (22 eyes)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Silicone oil (25 eyes)
Number of subjects: 47
Study: 9373658

Group type: EXPERIMENTAL
Intervention: Chloroquine (CQ)
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: Pyrimethamine/Sulfadoxine (PS)
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: Mefloquine (15 mg base/kg)
Number of subjects: 289
Study: 8385430

Group type: EXPERIMENTAL
Intervention: MK-886 (500 mg and 250 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 3083727

Group type: EXPERIMENTAL
Intervention: Group I (n = 6) with PaCO2 levels of 36 +/- 4 mmHg and 42 +/- 4 mmHg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Group II (n = 6) with PaCO2 levels of 47 +/- 3 mmHg and 53 +/- 3 mmHg
Number of subjects: 12
Study: 31112952

Group type: EXPERIMENTAL
Intervention: Hybrid Laparoendoscopic Single-Site Surgery (hLESS)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Conventional Three-Port Laparoscopy (TPL)
Number of subjects: 61
Study: 27100959

Group type: EXPERIMENTAL
Intervention: Captopril (50 mg three times a day for 1 year)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Observation (standard care)
Number of subjects: 81
Study: 26620151

Group type: COMPARATOR
Intervention: GSK2256294 2-20 mg single escalating doses
Number of subjects: 0

Group type: COMPARATOR
Intervention: GSK2256294 6 or 18 mg once daily for 14 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: GSK2256294 10 mg single dose
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 24823461

Group type: EXPERIMENTAL
Intervention: GH treatment: 33 or 67 μg/kg · d
Number of subjects: 151

Group type: COMPARATOR
Intervention: Untreated controls
Number of subjects: 151